Sinopharm Group Co. Ltd.
Символ: 1099.HK
HKSE
21.5
HKDПазарна цена днес
4.5308
Съотношение P/E
0.0000
Коефициент PEG
64.88B
MRK Cap
- 0.05%
Доходност на DIV
Sinopharm Group Co. Ltd. (1099-HK) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 185555.15 | 63809.1 | 55222.1 | 43541.2 | ||||||||||||||||||
balance-sheet.row.short-term-investments | 1.81 | 0.5 | 0.5 | 11.7 | ||||||||||||||||||
balance-sheet.row.net-receivables | 840931.45 | 185790.4 | 201909.9 | 172575.5 | ||||||||||||||||||
balance-sheet.row.inventory | 244868.46 | 60027.6 | 60925.8 | 51499.6 | ||||||||||||||||||
balance-sheet.row.other-current-assets | 294059.24 | 27208.6 | 1348.5 | 20506 | ||||||||||||||||||
balance-sheet.row.total-current-assets | 1353659.49 | 336835.1 | 319406.4 | 290922.1 | ||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 76726.11 | 19897.7 | 17792.4 | 17597.5 | ||||||||||||||||||
balance-sheet.row.goodwill | 7155.58 | 0 | 7155.6 | 7199 | ||||||||||||||||||
balance-sheet.row.intangible-assets | 35496.73 | 10196.1 | 4870.1 | 5003 | ||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 42652.31 | 10196.1 | 12025.7 | 12202 | ||||||||||||||||||
balance-sheet.row.long-term-investments | 40122.85 | 10550.7 | 9840 | 9172.5 | ||||||||||||||||||
balance-sheet.row.tax-assets | 6104.38 | 0 | 1979.7 | 1787.1 | ||||||||||||||||||
balance-sheet.row.other-non-current-assets | 16776.27 | 5915.3 | 3731 | 3731.1 | ||||||||||||||||||
balance-sheet.row.total-non-current-assets | 182381.93 | 46559.7 | 45368.8 | 44490.2 | ||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.total-assets | 1536041.42 | 383394.8 | 364775.1 | 335412.3 | ||||||||||||||||||
balance-sheet.row.account-payables | 579164.9 | 146632.5 | 144616.7 | 132866.9 | ||||||||||||||||||
balance-sheet.row.short-term-debt | 263825.29 | 54730.4 | 54633.2 | 56699.7 | ||||||||||||||||||
balance-sheet.row.tax-payables | 5827.1 | 0 | 3278.7 | 3008.1 | ||||||||||||||||||
balance-sheet.row.long-term-debt-total | 64488.41 | 17254.9 | 14957 | 11668.5 | ||||||||||||||||||
Deferred Revenue Non Current | 834.06 | 0 | 413 | 376.2 | ||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 2817.19 | - | - | - | ||||||||||||||||||
balance-sheet.row.other-current-liab | 163749.93 | 40127.7 | 35713.1 | 8119.6 | ||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 83054.71 | 21585.5 | 19743 | 16451.8 | ||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 19863.61 | 5217.4 | 4842.5 | 4797.9 | ||||||||||||||||||
balance-sheet.row.total-liab | 1089794.83 | 263076.1 | 254705.9 | 235758.4 | ||||||||||||||||||
balance-sheet.row.preferred-stock | 4390.58 | 0 | 4390.6 | 4388.1 | ||||||||||||||||||
balance-sheet.row.common-stock | 12482.62 | 3120.7 | 3120.7 | 3120.7 | ||||||||||||||||||
balance-sheet.row.retained-earnings | 92280.15 | 49410.1 | 42870.1 | 38515.8 | ||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 144276.58 | 22055.3 | -4390.6 | -4388.1 | ||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 22066.3 | -3.8 | 22077.8 | 20249.6 | ||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 275496.23 | 74582.2 | 68068.6 | 61886 | ||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 1536041.42 | 383394.8 | 364775.1 | 335412.3 | ||||||||||||||||||
balance-sheet.row.minority-interest | 170750.36 | 45736.5 | 42000.6 | 37767.9 | ||||||||||||||||||
balance-sheet.row.total-equity | 446246.59 | 120318.7 | 110069.2 | 99653.9 | ||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 1536041.42 | - | - | - | ||||||||||||||||||
Total Investments | 40124.66 | 10551.2 | 9840.5 | 9184.3 | ||||||||||||||||||
balance-sheet.row.total-debt | 328313.71 | 71985.3 | 69590.2 | 68368.2 | ||||||||||||||||||
balance-sheet.row.net-debt | 142760.38 | 8176.8 | 14368.6 | 24838.8 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 13885.67 | 18563.8 | 17003.2 | 15598.1 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 6431.19 | 4165 | 3922.1 | 3597.1 | |||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | -2547.1 | |||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | -18.6 | |||||||||||||||||
cash-flows.row.change-in-working-capital | 36867.54 | -2073.7 | -12101.3 | -8720 | |||||||||||||||||
cash-flows.row.account-receivables | 40823.4 | 710.1 | -26717.2 | -22631.4 | |||||||||||||||||
cash-flows.row.inventory | -3955.85 | -9504.2 | -4345.3 | -3675.4 | |||||||||||||||||
cash-flows.row.account-payables | 2600.46 | -710.1 | 26717.2 | 22631.4 | |||||||||||||||||
cash-flows.row.other-working-capital | -2600.46 | 7430.5 | -7756 | -5044.6 | |||||||||||||||||
cash-flows.row.other-non-cash-items | 12380.75 | 308.6 | 484.2 | 3245 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 73221.35 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -3928.64 | -2417.5 | -2255.6 | -2087.3 | |||||||||||||||||
cash-flows.row.acquisitions-net | -315.42 | -336.7 | -488.4 | -2427.4 | |||||||||||||||||
cash-flows.row.purchases-of-investments | 300.81 | -100 | -75 | -40 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 46.19 | 211.5 | 298.6 | 23.7 | |||||||||||||||||
cash-flows.row.other-investing-activites | -789.73 | -946.9 | 1253.4 | 2328.3 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -4686.8 | -3589.6 | -1267 | -2202.8 | |||||||||||||||||
cash-flows.row.debt-repayment | -80833.37 | -101705.3 | -104707.1 | -96838.2 | |||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 3600.4 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 96841.4 | |||||||||||||||||
cash-flows.row.dividends-paid | 0 | -2340.5 | -2153.3 | -1865.1 | |||||||||||||||||
cash-flows.row.other-financing-activites | 824.82 | 98352.3 | 92167.4 | 287.4 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -34661.67 | -5693.5 | -14693 | 2025.9 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -10.47 | 11.5 | 3 | 8.6 | |||||||||||||||||
cash-flows.row.net-change-in-cash | 33862.42 | 11692.2 | -6648.8 | 10986.3 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 186667.49 | 55221.6 | 43529.4 | 50178.3 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 152805.07 | 43529.4 | 50178.3 | 39192 | |||||||||||||||||
cash-flows.row.operating-cash-flow | 73221.35 | 20963.8 | 9308.1 | 11154.6 | |||||||||||||||||
cash-flows.row.capital-expenditure | -3928.64 | -2417.5 | -2255.6 | -2087.3 | |||||||||||||||||
cash-flows.row.free-cash-flow | 69292.72 | 18546.3 | 7052.4 | 9067.3 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 887304.96 | 596569.6 | 552147.6 | 521051.2 | ||||||||||||||||||
income-statement-row.row.cost-of-revenue | 812957.15 | 548057.9 | 504713.5 | 477000.6 | ||||||||||||||||||
income-statement-row.row.gross-profit | 74347.81 | 48511.7 | 47434.1 | 44050.6 | ||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.selling-general-administrative | 13199.35 | - | - | - | ||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 26487.34 | - | - | - | ||||||||||||||||||
income-statement-row.row.other-expenses | 37.67 | 0 | -676.2 | -589.2 | ||||||||||||||||||
income-statement-row.row.operating-expenses | 78456.8 | 26837.3 | 24227 | 22609.3 | ||||||||||||||||||
income-statement-row.row.cost-and-expenses | 853548.58 | 574895.2 | 528940.4 | 499610 | ||||||||||||||||||
income-statement-row.row.interest-income | 3637.12 | 2162.3 | 542.8 | 558.6 | ||||||||||||||||||
income-statement-row.row.interest-expense | 1633.81 | 0 | 3520.3 | 3756.8 | ||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 26487.34 | - | - | - | ||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -4151.85 | -2806.3 | -2040.6 | -2708.8 | ||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.other-operating-expenses | 37.67 | 0 | -676.2 | -589.2 | ||||||||||||||||||
income-statement-row.row.total-operating-expenses | -4151.85 | -2806.3 | -2040.6 | -2708.8 | ||||||||||||||||||
income-statement-row.row.interest-expense | 1633.81 | 0 | 3520.3 | 3756.8 | ||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 3592.15 | 2271.4 | 8204.8 | 7153.1 | ||||||||||||||||||
income-statement-row.row.ebitda-caps | 37390.69 | - | - | - | ||||||||||||||||||
income-statement-row.row.operating-income | 33798.54 | 22318.5 | 20604.5 | 19712 | ||||||||||||||||||
income-statement-row.row.income-before-tax | 29646.68 | 19512.1 | 18563.8 | 17003.2 | ||||||||||||||||||
income-statement-row.row.income-tax-expense | 6929.82 | 4502.3 | 4218.4 | 3938.4 | ||||||||||||||||||
income-statement-row.row.net-income | 13714.36 | 9053.8 | 14345.4 | 13064.8 |
Често задавани въпроси
Какво е Sinopharm Group Co. Ltd. (1099.HK) общи активи?
Sinopharm Group Co. Ltd. (1099.HK) общите активи са 383394844000.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 440588767623.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е 22.232.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е 22.232.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е 0.015.
Какъв е общият приход на предприятието?
Общият приход е 0.038.
Каква е Sinopharm Group Co. Ltd. (1099.HK) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е 9053760000.000.
Какъв е общият дълг на фирмата?
Общият дълг е 71985327000.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 26837263000.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са 63808538000.000.